Virtual Event
From Breakthrough to Bedside: Aligning Regulatory Strategy, Clinical Evidence and Commercialization in Diagnostics
June 17 @ 9:00 am - 10:00 am
Virtual Event
This panel will examine how diagnostics innovators can effectively move from concept to market adoption. The discussion will cover critical intersections between regulatory strategy, clinical validation and commercialization, including FDA pathways, clinical study design and how to position programs for investment and scale.
Speakers include:
› Sarah Melaney, Pillsbury Partner (Moderator)
› Steven Green, Pillsbury Partner (Panelist)
› Joen Johansen, President & CEO of MDC Associates (Panelist)
› Michele Colucci, Founding Managing Partner of DigitalDX (Panelist)
Hosted by:
